deltatrials
Completed OBSERVATIONAL NCT03114618

A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient (ONCOTHROMB)

Genomic Predictors Indicating the Risk of Venous Thromboembolic Disease in Cancer Patients Treated in Outpatient Clinics

Sponsor: Andres muñoz

Conditions Cancer-associated Thrombosis Genetic Predisposition
Updated 14 times since 2017 Last updated: Apr 7, 2022 Started: Mar 31, 2013 Primary completion: Dec 31, 2020 Completion: Feb 28, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Cancer-associated Thrombosis and Genetic Predisposition and is currently completed. Andres muñoz leads this study, which shows 14 recorded versions since 2013 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~May 2017 – ~Aug 2017 · 3 months · monthly snapshot~Aug 2017 – ~Feb 2018 · 6 months · monthly snapshot~Feb 2018 – ~Apr 2018 · 59 days · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Sep 2020 · 27 months · monthly snapshot~Sep 2020 – ~Nov 2020 · 2 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~May 2022 · 5 months · monthly snapshot~May 2022 – ~Jul 2024 · 26 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. May 2022 — Jul 2024 [monthly]

    Completed

  5. Dec 2021 — May 2022 [monthly]

    Completed

▶ Show 9 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Completed

  2. Nov 2020 — Jan 2021 [monthly]

    Completed

  3. Sep 2020 — Nov 2020 [monthly]

    Completed

  4. Jun 2018 — Sep 2020 [monthly]

    Completed

  5. May 2018 — Jun 2018 [monthly]

    Completed

  6. Apr 2018 — May 2018 [monthly]

    Completed

    Phase: NA → None

  7. Feb 2018 — Apr 2018 [monthly]

    Completed NA

  8. Aug 2017 — Feb 2018 [monthly]

    Completed NA

  9. May 2017 — Aug 2017 [monthly]

    Completed NA

    First recorded

Mar 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Andres muñoz
  • Complejo Hospitalario Universitario de Vigo
  • Complejo Universitario Torrecárdenas, Almería
  • Complexo Hospitalario de Ourense
  • Ferrer inCode, S.L.
  • Gendiag
  • Hospital Clinic of Barcelona
  • Hospital General Universitario Elche
  • Hospital General de Ciudad Real
  • Hospital Obispo Polanco, Teruel
  • Hospital Universitario La Paz
  • Hospital Universitario Marqués de Valdecilla
  • Hospital Universitario Ramon y Cajal
  • Hospital Universitario de Fuenlabrada
  • Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
  • LEO Pharma
  • Servicio de Oncología Médica. HGU Gregorio Marañón. Madrid
  • Sociedad Española de Oncología Médica (SEOM)
  • Sociedad Española de Trombosis y Hemostasia (SETH)
  • Unitat d'Hemostasia i Trombosi. Hospital de la Santa Creu i Sant Pau
  • Unitat de Genòmica de Malalties Complexes. Institut d'Investigació Sant Pau
  • University Hospital Virgen de las Nieves
Data source: Hospital General Universitario Gregorio Marañon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations